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Materials and Methods  
Materials. The plasmids pB18D and pB30D, which encode the cell surface-displayed 26-10 
anti-digoxigenin single chain variable fragment (scFv) in pBAD18 and pBAD30 vector back-
bones, were generous gifts from Professor George Georgiou.[1] The plasmid pAK400, a vector 
used for periplasmic expression scFvs, was a generous gift from Professor Andreas Plück-
thun.[2] The plasmids pQE-80L and pREP4 were obtained from Qiagen (Valencia, CA). All DNA 
oligomers were purchased from Integrated DNA technologies (IDT, Coralville, Iowa), and all 
restriction enzymes were obtained from New England Biolabs (Ipswich, MA). DNA polymeras-
es for cloning and for error prone PCR (Mutazyme II) were obtained from Stratagene/Agilent 
(Santa Clara, CA), and deoxynucleoside triphosphates were obtained from either Stratagene 
or Roche (Indianapolis, IN). The E. coli cell strains XL-1 Blue and DH10B were obtained from 
Qiagen and Invitrogen (Carlsbad, CA), respectively. The methionine auxotrophic E. coli strain 
TYJV2 was made in-house using the red recombinase gene knockout method of Datsenko 
and Wanner to eliminate the gene metE from E. coli strain DH10B.[3,4] Chemical reagents were 
purchased from Sigma-Aldrich (Madison, WI) unless otherwise noted. Canonical amino acids 
and L-norleucine (Nrl, 4) were obtained from Sigma-Aldrich. L-Homopropargylglycine (Hpg, 2) 
was purchased from Chiralix (Nijmegen, Netherlands). L-Azidohomoalanine (Aha, 3) was syn-
thesized by the method of Link et al.[5] with minor modifications. BODIPY FL Digoxigenin 5 
used in flow cytometry experiments was a generous gift from Professor Patrick Daugherty 
(originally purchased from Invitrogen), and propidium iodide for viability staining was from Invi-
trogen. Streptavidin-phycoerythrin (SA-PE) was purchased from EBioSciences. Isopropyl-β-D-
thiogalactoside (IPTG) was obtained from Gold Biosciences. Dibenzocyclooctyne Alexa Fluor 
488 6 was purchased from Invitrogen. Synthesis of biotin cyclooctyne 7[6,7] has been described 
previously. Tris(3-hydroxypropyltriazolylmethyl)amine (THPTA) and 3-azidopropanol were pre-
pared in-house by Janek Szychowski. THPTA was synthesized as described previously,[8] and 
3-azidopropanol was prepared by azide displacement of bromine in 3-bromopropanol. The 
amine-reactive version of digoxigenin, 3-amino-3-deoxydigoxigenin hemisuccinamide, succin-
imidyl ester, was purchased from Invitrogen. Bovine serum albumin was from Equitech Bio 
(Kerrville, TX) or Pierce (Rockford, IL). Columns used in protein purification and reagents used 
in Biacore assays were obtained from GE Healthcare Life Sciences (Picataway, NJ). Nickel-
nitrilotriacetic acid (Ni-NTA) resin was purchased from Qiagen. Dialysis membranes were from 
Spectrum Labs (Rancho Dominguez, CA). Nitrocellulose membrane was from GE Healthcare 
Life Sciences. Alexa Fluor 647-labeled anti-penta-His antibodies were purchased from Qiagen. 
Sequencing grade porcine trypsin was purchased from Promega (Madison, WI). Desalting col-
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umns for purifying mass spectrometry samples were purchased from Millipore (Billerica, MA). 
Zeba spin desalting columns for small-scale buffer exchanges were from Pierce, and PD-10 
desalting columns for intermediate volume buffer exchanges were from GE Healthcare Life 
Sciences. 
 
Cloning and library construction. The plasmid pQE-80L-antidig-HisGS-Base was construct-
ed in several steps. An EcoRI site in pB30D was eliminated via site-directed mutagenesis us-
ing the primer EcoRIElimFwd (sequence given in Table S10) and its reverse complement 
EcoRIElimRev. This resulted in the generation of plasmid pJAV2, which was confirmed by DNA 
sequencing. The Lpp-OmpA-scFv fusion was then amplified in two steps from pB18D. In the 
first step, an internal HindIII site was eliminated by performing two PCRs. The 5’-fragment was 
amplified using primers Lpp-OmpA-antidigFwd and HindIIIElimRev, and the 3’-fragment was 
amplified using HindIIIElimFwd and Lpp-OmpA-antidigRev1. After gel purification, a second 
amplification with the 5’- and 3’-fragments and primers Lpp-OmpA-antidigFwd and Lpp-OmpA-
antidigRev2 was undertaken. The purified PCR product and pJAV2 were doubly digested with 
XmaI and HindIII and ligated. After transformation of electrocompetent XL-1 Blue cells and se-
lection on plates containing chloramphenicol, clones containing the correctly sized insert were 
verified by DNA sequencing at Laragen (Culver City, CA). The resulting plasmid was designat-
ed pJAV2-antidig-RGSHis. This plasmid was used as a template for additional PCR amplifica-
tion of the Lpp-OmpA-scFv fusion with Lpp-OmpA-antidigFwd and LppHisRescue. Double di-
gestion of pQE-80L and the PCR product with HindIII and XmaI, purification, and ligation re-
sulted in pQE-80L-antidig-HisGS, which was validated by DNA sequencing. Introduction of re-
striction sites into the Lpp-OmpA-scFv fusion gene at locations suitable for library construction 
was accomplished through assembly PCR. Four PCRs were performed in which pQE-80L-
antidig-HisGS was amplified with the following pairs of primers: 80LLibFwd and PstIAddRev; 
PstIAddFwd and PstIElimRev; PstIElimFwd and BglIIAddRev; BglIIAddFwd and 80LLibRev. 
The resulting four PCR products were gel purified, mixed, and amplified using the primers 
80LLibFwd and 80LLibRev. The PCR product was gel purified and doubly digested with HindIII 
and XmaI along with pQE-80L. The digestion products were gel purified, ligated, and trans-
formed into electrocompetent E. coli XL-1 Blue cells, which were plated on ampicillin plates. 
Colonies were tested for the proper insert size and sequence verified for the desired restriction 
site modifications (PstI and BglII), resulting in plasmid pQE-80L-antidig-HisGS-Base. The in-
troduction of these restriction sites shortly after the Lpp portion of the construct and after the 
scFv sequence did not appear to affect the function of the display construct when compared to 
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pQE-80L-antidig-HisGS or pB18D. Use of pQE-80L-antidig-HisGS-Base and related display 
plasmids was always performed in cells containing pREP4 in order to maximize the amount of 
constitutively expressed laqIq gene product, which is encoded in pQE-80L derivatives and in 
pREP4. 
 Libraries were constructed using pQE-80L-antidig-HisGS-Base (Library 1) or the thrice-
sorted Library 1 after expression in medium containing Hpg (Library 2) as templates for error-
prone PCR. The polymerase Mutazyme II from the Stratagene GeneMorph II kit was used to 
introduce errors throughout the Lpp-OmpA-scFv gene at targeted error rates of roughly two to 
five mutations per gene (Lpp and histidine tags excluded from mutagenesis). After an initial 
error-prone PCR step, additional amplification of DNA was performed using a higher fidelity 
polymerase. The insert and pQE-80L-antidig-HisGS-Base were doubly digested with PstI and 
BglII. After gel purification and ligation, the resulting DNA was used to transform electrocompe-
tent E. coli TYJV2 cells (~200 µL) containing pREP4. These cells were rescued for 1 hour in 
super optimized broth with catabolic repression (SOC; 20–25 mL), followed by inoculation into 
2×YT medium (0.25–1.0 L) containing ampicillin (200 mg/L) and kanamycin (34 mg/L) (2×YT 
KA). Before growing cells, small amounts (~0.5–50 µL) of the broth were distributed on agar 
plates containing ampicillin and kanamycin in order to estimate the total number of trans-
formants in the library. The libraries were grown at 37 °C until surpassing an OD600 of 1.0, and 
plates were incubated at 37 °C until colonies were large enough to count. Plasmid DNA was 
isolated from culture (~200 mL) using a Qiagen Maxiprep kit. Aliquots of cells containing the 
library were stored at a 1:1 ratio with cell stock buffer (65% glycerol (vol/vol), 25 mM Tris, 100 
mM MgSO4, pH 8.0) and frozen at −80 °C. In the construction of Library 1, two separate trans-
formations were performed (1 and 1a), aliquoted, and maxiprepped. Colony counts indicated 
that transformation 1 yielded about 4.5 × 105 transformants, while transformation 1a yielded 
roughly 7.7 × 104 transformants. Random picking of ten clones revealed nine with the proper 
insert. Sequencing of these transformants using the primer 80LLibFwd revealed an approxi-
mate error rate of 2.7 mutations per kilobase, or 3.0 per gene. Construction of Lib2 resulted in 
approximately 5.6 × 106 transformants. Restriction fragment analysis of twelve clones showed 
that all twelve transformants selected had the proper inserts. Sequencing of ten clones using 
80LLibRev revealed an approximate error rate of 4.2 mutations per kilobase, or 4.7 per gene, 
in Lib2 relative to Base (this includes mutations acquired during the first round of screening). 
 Miniprepped plasmid DNA isolated from sorted libraries was transformed into fresh 
TYJV2 cells containing pREP4; the transformed cells were grown on 2×YT plates supplement-
ed with ampicillin and kanamycin. Individual colonies were randomly picked from plates, sub-
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jected to medium shifts and flow cytometry experiments to determine binding function on-cell 
(see below), miniprepped, and sequenced. The scFv portions of DNA from the variants to be 
studied in soluble form were PCR amplified using primers AntidigpAK400Fwd and Anti-
digpAK400Rev with the exception of clone Nrl4x3, which contained a mutation within the prim-
ing region of AntidigpAK400Fwd and was therefore amplified in the forward direction with the 
primer AntidigpAK400FwdNrl4x3. After PCR amplification, all PCR products and the vector 
pAK400 were digested with SfiI. Ligation of scFv genes and vector were performed using the 
New England Biolabs Quick Ligation Kit and transformed into electrocompetent DH10B cells. 
These cells were grown on agar plates at 30 °C containing chloramphenicol (35 mg/L) and 
glucose (1 % weight/vol). Resistant colonies were grown at 30 °C in liquid culture containing 
chloramphenicol and glucose, miniprepped, tested for the desired inserts, and verified by se-
quencing. 
 
Expression of cell surface display constructs. Expression of all cell surface-displayed se-
quence variants and library populations to be studied via flow cytometry was performed using 
a standard medium shift procedure suitable for cell surface display.[9] On the day of expres-
sion, cells harboring the sequence variants or populations of interest were grown at 37 °C in 
M9 minimal medium (M9 salts containing glucose (0.4% w/v), thiamine hydrochloride (35 
mg/L), MgSO4 (1 mM), CaCl2 (0.1 mM), and 20 amino acids (40 mg/L)) supplemented with 
ampicillin (200 mg/L), and kanamycin (35 mg/L) (M9 KA Glucose 20AA). Upon reaching an 
OD600 of roughly 0.5–1.0, cells were pelleted (7 minutes at 6000 × g in a fixed angle rotor or 10 
minutes at 3000–4000 × g in a variable angle rotor), resuspended in minimal medium lacking 
Met, and allowed to grow at 37 °C for ten minutes. Cells were again pelleted and resuspended 
in minimal medium lacking Met and supplemented with Met or with the ncAA of interest. Cells 
were induced with IPTG (1 mM) and allowed to grow at 25 °C. After 6 hours, cells were pellet-
ed and prepared for flow cytometry according to procedures described below. 
 
Flow cytometry, Library 1. A single colony bearing plasmids pQE-80L-antidig-HisGS-Base 
(Base) and pREP4 was used to inoculate an overnight culture of minimal medium (2 mL) con-
taining the twenty canonical amino acids, kanamycin, ampicillin, and glucose (M9 KA Glucose 
20AA) and then grown overnight at 37 °C. The culture was then diluted 1:100 into fresh M9 KA 
Glucose 20AA (~10 mL). In the initial round of screening, equal volumes of transformations 1 
and 1a were mixed, diluted 1:30 into M9 KA Glucose 20AA (60 mL), and grown at 37 °C. After 
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reaching OD600 = 0.7–0.8, cells were shifted into new medium as described above. Cells bear-
ing pQE-80L-Antidig-HisGS-Base were aliquoted (3–4 mL/aliquot) and induced with IPTG 
(1 mM) in M9 KA Glucose containing 20 amino acids or 19 amino acids (−Met) supplemented 
with Hpg (2.5 mM). Cells bearing Library 1 were aliquoted into several small samples and in-
duced in medium containing twenty canonical amino acids or 19 amino acids (−Met) with Hpg 
(2.5 mM) supplemented with Met (0, 10, 20, or 30 µM). After 6 hours, cells were pelleted, 
washed once in phosphate-buffered saline (PBS, pH 7.4: 8.00 g/L NaCl, 0.20 g/L KCl, 1.15 g/L 
Na2HPO4H2O, 0.20 g/L KH2PO4), and resuspended in PBS to an OD600 of 1.0. Cells were 
then treated with 5 (200 nM) in aliquots (0.25–1.0 mL) for at least 45 minutes with gentle agita-
tion at room temperature, diluted 1:20 into PBS, and filtered using filters (25 mm diameter) 
containing Acrodisc Supor membranes (5 µm; Pall Life Sciences, Ann Arbor, Michigan). 
 A MoFlo flow cytometer (Beckman Coulter, Miami, FL) was used for all scanning and 
library sorting. Control experiments confirmed that expression of Base in media supplemented 
with Met yielded cells exhibiting high fluorescence after exposure to 5, while cells expressed in 
Hpg (2.5 mM) exhibited low fluorescence levels after exposure to 5, confirming that the medi-
um shift was successful. Library 1 expressed in Hpg (2.5 mM) and Met (20 µM) was judged to 
have a sufficient number of positive events to make it suitable for sorting. A gate was set to 
collect the brightest ~0.1 % of the events, and sorting was allowed to proceed for a total of 
35 million events in the sort mode Single 1. Approximately 36,000 events satisfied the gating 
criteria and were deposited directly into a tube of SOC medium on ice. Upon completion of the 
sort, cells were rescued for 1 hour at 37 °C in SOC (2.5 mL), diluted with 2×YT medium 
(10.5 mL) containing ampicillin and kanamycin, and allowed to grow overnight at 37 °C. The 
next day, aliquots of the sorted population were mixed 1:1 with cell stock buffer and frozen at 
−80 °C. The remaining rescued cells were miniprepped in order to isolate plasmid DNA from 
the sort. Subsequent rounds of expression, scanning, and sorting were performed as de-
scribed above, with a frozen aliquot from the previous round of sorting used as the input for 
the next round of expression and cell sorting. In rounds 2 and 3, the population to be sorted 
was expressed in M9 KA Glucose containing nineteen amino acids plus Hpg (2.5 mM; no Met). 
Sorting was performed with comparable stringencies and event totals as in round 1. 
 Miniprepped DNA from the third round of sorting was used to transform electrocompe-
tent TYJV2 cells containing pREP4. Cells were rescued for 1 hour with SOC and plated on 
agar containing ampicillin and kanamycin. Ten colonies were chosen randomly for sequencing 
and characterization. Following inoculation into M9 KA Glucose 20AA and overnight growth at 
37 °C, cells were diluted 1:100 into fresh M9 KA Glucose 20AA and 1:200 into fresh 2×YT 
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supplemented with kanamycin and ampicillin (2×YT KA). Cells in minimal media were then 
subjected to medium shifts, induced with IPTG (1 mM) in Hpg (2.5 mM) for 6 hours, and har-
vested. Cells were treated with 5 (200 nM) and subjected to flow cytometry to assess binding 
in the Hpg amino acid context. Cells grown in 2×YT KA were miniprepped for plasmid DNA 
and submitted for sequencing with the primers 80LLibFwd and 80LLibRev. 
 
Flow cytometry, Library 2. Rounds one and two of sorting of Library 2 in various amino acid 
contexts were performed essentially as described for sorting Library 1. Aliquots of the library 
were thawed and diluted 1:30 into fresh M9 KA Glucose 20AA, grown, shifted into fresh medi-
um, and subjected to 6-hour induction of protein expression in medium containing either Met 
(0.27 mM), Hpg (2.5 mM), Aha (0.28 mM), or Nrl (0.30 mM). In round 1, cells were sorted in 
Purify 1 mode after treatment with 5 (200 nM), dilution, and filtering. A total set of events num-
bering more than ten times the library size was screened in each amino acid context, with 
0.2%–0.5% of the most fluorescent events retained and rescued as described above. In round 
2, the populations were treated with a reduced concentration (100 nM) of 5 prior to screening, 
and 0.1%–0.2% of the most fluorescent events were retained and rescued. 
 Beginning with the third round of sorting, significant changes were made to the expres-
sion and sorting protocol. Frozen aliquots of library fractions were thawed and diluted 1:100 
into fresh M9 KA Glucose 20AA and allowed to grow to saturation overnight at 37 °C, then di-
luted 1:50 the next morning into fresh M9 KA Glucose 20AA and grown, medium shifted, and 
induced for 6 hours with IPTG (1 mM). Cells were washed once in PBS, and library fractions of 
cells induced in the presence of ncAAs were resuspended at an OD600 of 0.2. The library frac-
tion Hpg2x expressed in Hpg was sorted on the same day it was induced. The library fraction 
was treated with 5 (100 nM), with control samples (i.e., library fractions expressed in Met and 
Base in Met and Hpg) resuspended and treated with 5 (100 nM) at an OD600 of 1.0. All other 
populations to be sorted (i.e., Aha2x, Aha3x, Hpg3x, Nrl2x, and Nrl3x) were incubated with 
gentle agitation overnight at 4 °C in PBS along with control samples (at the OD600s listed 
above). 
 Washing, viability staining, and kinetic competitions were used with all samples to be 
sorted in rounds three and four of sorting in an attempt to enrich sorted populations for clones 
with improved kinetic properties and to exclude dead cells. Samples to be sorted were treated 
with 5 (100 nM) for at least 45 minutes before being washed twice in PBS, diluted, filtered, and 
scanned. Cells were also treated with propidium iodide (PI; 5 µM) at least five minutes before 
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being scanned on the flow cytometer. Prior to sorting library fractions, the kinetic competition 
method of Daugherty et al. was employed.[10] Two kinetic competitions were run in parallel: 
cells to be monitored as a function of time were washed twice after treatment with 5, diluted to 
an OD600 of 0.05, filtered, and exposed to PI prior to competition. The population to be sorted 
was washed twice after treatment with 5 and diluted to an OD600 of 0.5 without exposure to PI 
prior to competition. The cells diluted to OD600 = 0.05 were scanned on the flow cytometer, and 
then competition was initiated in both samples by adding unlabeled digoxin (2 µM). Total com-
petition duration was determined empirically by monitoring the competition progress with 
scans of the more dilute cells every 5 minutes. When the mean fluorescence of the scanned 
population had been reduced by roughly 40%–60%, the competition of the cells at OD600 = 0.5 
was stopped by washing the cells twice in ice-cold PBS. Cells were then diluted to an OD600 of 
0.05, filtered, treated with PI, and sorted on the MoFlo using sort mode Single 1. Approximate-
ly 0.1%–1% of events were retained in each sort, which was gated to isolate cells exhibiting 
high levels of fluorescence after kinetic competition while excluding dead cells, doublets, and 
other aberrant events. Events totaling at least ten times the size of the sorted population (≤ 
30,000 distinct clones, based on the number of events retained in previous sorts) were 
scanned in the course of a sort. Cells were retained and rescued as above. 
 
On-cell estimates of dissociation constants. Individual clones from sorted library popula-
tions were obtained by transforming electrocompetent TYJV2 cells containing pREP4 with 
plasmid DNA samples from sorted populations Hpg3x, Aha3x, Hpg4x, Aha4x, and Nrl4x. 
Transformed cells were then allowed to grow on agar plates supplemented with ampicillin and 
kanamycin. Individual colonies were picked and used to inoculate liquid cultures in M9 KA 
Glucose 20AA and grown overnight at 37 °C. The next morning, samples were diluted 1:50 in-
to fresh M9 KA Glucose 20AA and grown at 37 °C in preparation for medium shifts. During the 
medium shifts performed on cells bearing individual mutants, a portion of each culture was di-
luted into fresh 2×YT KA and allowed to grow to saturation. Plasmid DNA from the 2×YT cul-
tures was extracted and subsequently sequenced to determine the mutations present in each 
clone. Another portion of cells was shifted into fresh medium, and protein expression was in-
duced in the ncAA context in which the clones were isolated. After expression, all cells were 
washed once and resuspended in PBS at an OD600 of 1.0 and kept at 4 °C overnight with gen-
tle agitation. The next day, samples were treated with 5 (100 nM) for at least 45 minutes at an 
OD600 of 0.2 and stored on ice. While on ice, all samples to be used in kinetic dissociation ex-
periments[11] were treated with PI. Prior to scanning, samples that had been induced in the 
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presence of Met, Hpg, or Aha were washed twice and then resuspended in PBS, again con-
taining PI. For samples induced in the presence of Nrl, cells were pelleted, but not washed, 
prior to resuspension in PBS containing PI due to rapid loss of fluorescence in these samples. 
An initial scan of each clonal population was obtained prior to initiation of competition. Sam-
ples were then treated with unlabeled digoxin competitor (1 µM), mixed, and scanned every 60 
seconds over a period of 10 minutes. 
 Data from timed scans were analyzed using FlowJo (Tree Star, Ashland, OR) and Igor 
(Wavemetrics, Lake Oswego, OR) according to a previously described approach.[11] All sample 
scans were gated to exclude PI-positive cells from the analysis. The mean fluorescence of all 
PI-negative cells was then calculated. To eliminate background fluorescence from all samples, 
the mean fluorescence of a sample of cells containing pQE-80L-Antidig-HisGS-Base induced 
in the presence of Hpg (obtained on the same day as all data for kinetic dissociation experi-
ments and gated to eliminate PI-positive cells) was subtracted from the fluorescence of all 
other samples. The background-corrected data for an entire competition were then normalized 
based on the brightness of the sample of cells involved in the competition at t = 0 minutes. The 
resulting background-corrected, normalized data were fit to a first-order exponential equation 
of the form 
€ 
F = e−koff t ,  (S1) 
where F is the relative fluorescence of the sample compared to the sample at time t = 0 and 
koff is the dissociation rate constant. Results reported for all clones discussed here were per-
formed once and served as a means for identifying individual clones to study in more detail. 
On each day these experiments were performed, the rate constant of either Base induced in 
Met or the protein product of pQE-80L-Antidig-HisGS containing Met was estimated as a con-
trol for day-to-day consistency of technique. Data are reported in groups of samples that were 
all assayed at the same time. All data were analyzed using the program Igor (Wavemetrics, 
Lake Oswego, OR), and the errors reported are the 95% confidence intervals of the fits to 
Equation S1. 
 
Flow cytometry, simultaneous investigation of binding and chemical modification. 
TYJV2 cells containing a plasmid encoding cell surface-displayed Aha4x5 and the plasmid 
pREP4, and TYJV2 cells lacking plasmids were grown in M9 KA Glucose 20AA (cells contain-
ing plasmids) or M9 Glucose 20AA (cells without plasmids) as described above and induced 
with IPTG (1 mM) after using the standard cell surface display medium shift procedure, with 
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induction performed in medium containing either Met (0.27 mM) or Aha (1 mM). Samples left 
uninduced (TYJV2 cells with or without plasmids) were also subjected to medium shifts and 
expression conditions, without the addition of IPTG. After the 6-hour expressions, cells were 
washed twice in ice-cold PBS and resuspended to an OD600 of 1.0. Samples of cells were 
treated with biotin cyclooctyne 7 (100 µM) and incubated at 37 °C for 16 hours.[7] Additional 
portions of cultures were also incubated for 16 hours at 37 °C without exposure to 7. All sam-
ples were pelleted and resuspended, with cells treated with 7 washed twice in PBS prior to re-
suspension. Fluorescent probes were then added to probe the binding and modification states 
of cellular populations. All samples were treated with 5 (100 nM), a 1:100 dilution of streptavi-
din-phycoerythrin (SA-PE; 0.2 mg/mL), or both dyes simultaneously for a period of 45 minutes 
or longer. Cells displaying the Aha form of Aha4x5 were also treated with digoxin (10 µM) prior 
to exposure to 5 and SA-PE. After dye exposure, all samples were washed twice in PBS, dilut-
ed by at least tenfold, and filtered. 
 Samples were scanned using a MoFlo XDP flow cytometer (Beckman Coulter) upgrad-
ed from MoFlo to MoFlo XDP status by Propel Labs (Fort Collins, CO). Manual compensation 
was performed to enable simultaneous detection of BODIPY and phycoerythrin fluorescence 
without cross talk between fluorescence channels. Antigen binding and chemical modification 
were examined, first in separate experiments and then in a double-labeling experiment (Figure 
S6). A model sorting experiment was set up by combining four populations of cells bearing the 
plasmid encoding for Aha4x5: uninduced cells grown in Aha, induced cells expressed in Met, 
induced cells expressed in Aha blocked with unlabeled digoxin, and induced cells expressed in 
Aha. Each population was treated with 7 and exposed to 5 and SA-PE. Elliptical regions were 
established in the two-dimensional dot plot of BODIPY versus phycoerythrin fluorescence to 
capture populations of cells with various combinations of fluorescence properties. A four-way 
sort performed in Purify mode enabled isolation of cells with all possible combinations of high 
and low BODIPY and phycoerythrin fluorescence. The fluorescence properties of the isolated 
populations were examined by running each population on the flow cytometer immediately af-
ter completion of the sort. 
 
Expression and purification of soluble scFvs. TYJV2 colonies bearing individual scFv se-
quence variants in the pAK400 backbone were inoculated into M9 minimal medium (2 mL) 
containing twenty amino acids and glucose (0.4% weight/vol) supplemented with chloram-
phenicol (M9 Cam Glucose 20AA). Cells were allowed to grow at 30 °C for 4 or more hours, 
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diluted 1:20 into fresh M9 Cam Glucose 20AA (20–40 mL) and grown at 30 °C overnight. Satu-
rated cultures were then diluted 1:20 into M9 Cam Glucose 20AA (0.25–1.0 L) and grown at 
30 °C until reaching an OD600 of approximately 0.9–1.0. Cells were pelleted (15 minutes at 
5000 × g, 4 °C), washed three times in ice-cold NaCl (0.9% weight/vol), and resuspended in 
fresh M9 medium containing 19 amino acids (minus Met), glycerol (0.4% weight/vol), and chlo-
ramphenicol (M9 Cam Glycerol 19AA). Aliquots were supplemented with Met (0.27 mM), Hpg 
(1 mM), Aha (1 mM), or Nrl (2.3 mM) and grown at 25 °C for 30 minutes. Cultures were then 
induced with IPTG (1 mM) and allowed to grow for 4 hours at 25 °C. 
 Upon completion of expression, cells were pelleted (15 minutes at 5000 × g, 4 °C) and 
resuspended vigorously in ice-cold Tris/sucrose buffer (0.75 M sucrose, 0.1 M Tris, pH 8.0; 32 
mL per liter culture volume). All subsequent scFv purification steps were performed at 4 °C or 
on ice unless otherwise noted. An adaptation of a previously described osmotic shock proce-
dure[12] was used to isolate the periplasmic fractions of cells, which contain the expressed 
scFvs. After resuspension, the Tris/sucrose buffer was supplemented with ice-cold lysozyme 
(10 mg/mL) in Tris/sucrose buffer (3.2 mL per liter culture volume). Pellets were rotated at 140 
RPM on ice during dropwise addition of ethylenediaminetetraacetic acid (EDTA; 1 mM; 64 mL 
per liter culture volume). After ten minutes (still with rotation), magnesium chloride (0.5 M; 3 
mL per liter culture volume) was added dropwise to the cell suspension. After another ten-
minute incubation period, the samples were pelleted (20 minutes at 10,000 × g, 4 °C). The su-
pernatants were dialyzed overnight against a solution of Ni-NTA start buffer (0.3 M NaCl, 0.05 
M NaH2PO4, 0.01 M imidazole, pH 8.0) at 4 °C using 12–14 kilodalton molecular weight cutoff 
(MWCO) dialysis tubing. Dialyzed samples were filtered using Acrodisc Supor filters (25 mm 
diameter with 5 µm pores) and incubated for 2–4 hours with Ni-NTA agarose prewashed with 
Ni-NTA start buffer (4.0 mL per liter culture volume resuspended slurry) at 4 °C. The Ni-NTA 
slurries were added to columns and the flow-through was collected. After two washes with Ni-
NTA wash buffer (0.3 M NaCl, 0.05 M NaH2PO4, 0.02 M imidazole, pH 8.0; 20 mL per liter cul-
ture volume), samples were eluted with Ni-NTA elution buffer (0.3 M NaCl, 0.05 M NaH2PO4, 
0.25 M imidazole, pH 8.0; 4 × 4.0 mL per liter culture volume). The presence of protein in the 
eluent was confirmed by spotting small portions of each elution fraction onto filter paper, stain-
ing the paper with coomassie blue stain (2.5 g/L coomassie blue and 2.5 g/L cupric sulfate in a 
solution of 5:4:1 water:ethanol:acetic acid) and destaining using 5:4:1 water:ethanol:acetic ac-
id. Fractions found to contain large amounts of protein were pooled and dialyzed against ion 
exchange start buffer (125 mM NaCl, 20 mM Tris, pH 8.0), saving aside small amounts of elu-
ent for sodium docedecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis. 
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 Ion exchange and size exclusion chromatography were performed on dialyzed eluents 
from Ni-NTA purification using an AktaPrime Plus fast performance liquid chromatography 
(FPLC, GE Healthcare) system at 4 °C. A HiTrapQ XL ion exchange column (1.0 mL bed vol-
ume) was used according to the manufacturer’s instructions with ion exchange start buffer and 
ion exchange high salt buffer (1 M NaCl, 20 mM Tris pH 8.0). The majority of scFv protein 
samples eluted during initial injection onto the column, while impurities tended to bind to the 
column until the salt concentration on the column was increased. The column flow-through 
containing scFv was collected, pooled, and concentrated (to a volume of 1.0–1.5 mL) using 
Amicon Ultra-15 10 kilodalton MWCO concentration devices primed with HBS +EDTA (150 
mM NaCl, 10 mM HEPES, 3 mM EDTA, pH 7.4). Size exclusion chromatography was per-
formed using a HiPrep 16/60 Sephacryl S-100 HR column using HBS +EDTA at a flow rate of 
1 mL/minute. This column allowed resolution of dimer and monomer scFv peaks. Fractions of 
monomeric protein were collected, pooled, and concentrated using Amicon Ultra-15 concentra-
tors. 
 
Protein characterization. All purification processes were assessed by SDS-PAGE analysis. 
After Ni-NTA, ion exchange, and size exclusion chromatography, all samples were found to be 
more than 90 % pure as judged by quantification of band intensities after colloidal blue staining 
(Invitrogen). Gels were imaged on a Typhoon Trio (GE Healthcare, Piscataway, NJ) imager, 
and the resulting images were processed using ImageQuant software (GE Healthcare). Con-
centrations of protein samples were determined using bicinchoninic acid (BCA) assay kits from 
Pierce. Proteins were stored in HBS +EDTA buffer at 4 °C long term. Size exclusion chroma-
tography on monomeric fractions of select proteins after storage for several months revealed 
no evidence of dimerization or aggregation. 
 Matrix-assisted laser desorption ionization (MALDI) mass spectrometry was performed 
on trypsinized samples in order to assess amino acid replacement levels. All samples to be 
examined were buffer exchanged into denaturing buffer (8 M urea, 0.1 M Tris, pH 8.0) using 
Amicon Ultra-0.5 mL concentration devices. Samples were reduced by treatment with tris(2-
carboxyethyl)phosphine (TCEP) (3.75 mM) at room temperature for 15 minutes. In the case of 
azide-containing samples, some samples were reduced with dithiothreitol (DTT; 2.5 mM) at 
55−60 °C for 15 minutes. Reduced samples were alkylated by the addition of iodoacetamide 
(12.5 mM) and incubation at room temperature in the dark for 15 minutes. Following alkylation, 
ammonium bicarbonate in water (50 mM, pH 7.8; 10 volumes) was added to each solution 
along with trypsin (Promega, 0.1 µg/µL stock concentration; 2.5–5 µL/sample); cleavage was 
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allowed to proceed overnight at 37 °C. Trifluoroacetic acid (TFA) was added to each cleaved 
sample (0.1 % final concentration), and C18 Zip Tips (Millipore) were used to desalt peptide 
samples according to the manufacturer’s protocol with one slight modification. In between wet-
ting and equilibrating the columns, a 50/50 acetonitrile/0.1% TFA solution was used to wash 
the columns. All samples were then mixed with α-cyano-4-hydroxycinnamic acid, dried on a 
MALDI target, and assayed on a Voyager DE Pro (Applied Biosystems, Carlsbad, CA) at the 
Caltech Division of Chemistry and Chemical Engineering Mass Spectrometry Facility. All ob-
served peptide masses fell within instrument tolerances of mass accuracies. Some Aha resi-
dues were converted to diaminobutyric acid residues during acquisition of MALDI mass spec-
tra.[13] 
 Incorporation levels of ncAAs were determined using processed MALDI mass spectra. 
All spectra were baselined and deisotoped using Data Explorer software (Applied Biosystems). 
The fraction of peptides bearing the ncAA substitution was calculated based on the counts of 
peaks corresponding to substituted and unsubstituted peptides. In most cases, the deisotoping 
procedure resulted in the presence of single peaks at the substituted and unsubstituted mass 
positions. In cases where the deisotoping still resulted in multiple peaks, the counts of all 
peaks corresponding to unsubstituted and substituted peptides were summed prior to calculat-
ing the fraction of substituted peaks. 
 MALDI mass spectrometry was also used on trypsinized and whole-protein samples in 
order to determine modification sites after click chemistry (see below). Trypsinized samples of 
modified proteins were prepared as described above. Whole-protein samples were also buffer 
exchanged into a denaturing buffer (8 M urea, 0.1 M Tris, pH 8.0). To each solution was added 
ammonium bicarbonate in water (50 mM, pH 7.8; 10 volumes), followed by addition of TFA 
(0.1 % final concentration). Protein samples were then desalted using C4 Zip Tips and further 
prepared for MALDI as described above. 
 
Protein modification. All strain-promoted click chemistry on soluble scFvs was performed us-
ing Alexa Fluor 488 dibenzocyclooctyne (DIBO) (6, Invitrogen). Compound 6 (10 µM) was 
added to solutions of Aha- or Met-containing scFvs (1.75 µM) in HBS +EDTA buffer. Solutions 
were vortexed briefly, and reaction was allowed to proceed for 1 hour at room temperature. 
Reactions were quenched by adding 3-azidopropanol (10–20 mM) and vortexing. 
 All dye-labeled proteins were run on denaturing SDS-PAGE gels in order to assess dye 
labeling. After electrophoretic separation, gels were destained in a solution of 50% methanol, 
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40% water, and 10% acetic acidic and rinsed in water. The Typhoon Trio was used to detect 
fluorescent bands on the gels. Gels were then stained overnight in colloidal blue staining solu-
tion, washed with water, and imaged again on the Typhoon Trio. Gel images were processed 
using ImageQuant software to assess the relative amounts of fluorescent dyes attached to 
protein samples of various types. Quantification of the extent of reaction between azide-
containing proteins and compound 6 was performed by using Alexa Fluor 488-labeled strep-
tavidin as an in-gel fluorescence standard. Absorbance measurements on a Cary 50 ultravio-
let-visible spectrophotometer (Agilent) were used to obtain protein concentrations and the ex-
tent of labeling of the concentrated fluorescent streptavidin standard. Known concentrations of 
standard and known protein quantities of labeled samples were run on SDS-PAGE gels and 
imaged as above. Establishment of a standard curve enabled estimation of the quantity of fluo-
rescent dye present in the bands of each experimental sample, and knowledge of the protein 
concentration enabled the number of dye molecules per protein to be calculated. Results re-
ported here are the averages of three triplicate experiments. In the case of the Aha form of 
Aha4x5, protein expressed and purified in two separate batches was used to estimate the ex-
tent of dye labeling. All other proteins assessed for extent of modification were from single 
batches of purified proteins. 
 
Western blotting. Digoxigenin-labeled bovine serum albumin (BSA) was prepared by conju-
gating amine-reactive 3-amino-3-deoxydigoxigenin hemisuccinamide, succinimidyl ester (Invi-
trogen) to BSA using reaction conditions described by the manufacturer. Briefly, BSA (10.2 mg) 
was dissolved in sodium bicarbonate (0.1 M, pH 9.0; 1 mL) and stirred in a scintillation vial. A 
small amount (≤ 1 mg) of 3-amino-3-deoxydigoxigenin hemisuccinamide, succinimidyl ester 
dissolved in N,N-dimethylformamide (150 µL) was added dropwise to the BSA solution. The 
mixture was stirred at room temperature for 5 minutes, diluted using PBS (final volume of 2.5 
mL) and run on a preequilibrated PD-10 desalting column in order to isolate the BSA from the 
unreacted labeling agent and to perform a buffer exchange into PBS. 
 Detection of digoxigenin-labeled BSA (BSA-Dig) in protein samples was achieved using 
standard Western blotting procedures. Samples of BSA and BSA-Dig mixed with E. coli ly-
sates (~5.5 µg/lane) were run on SDS-PAGE gels and transferred to nitrocellulose mem-
branes. Membranes were blocked for at least 1 hour in PBS containing TWEEN-20 (0.1%) and 
either BSA (3% weight/vol) or powdered milk solution (5% weight/vol) (Nestle, Glendale, CA). 
Membranes were washed in PBS containing TWEEN-20 (0.1%; PBS-TWEEN) before expo-
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sure to labeled scFvs. Antibody fragment samples (100–250 µL, 1.75 µM protein) treated with 
6 were diluted into PBS-TWEEN (approximately 10 mL) containing either BSA (3% weight/vol) 
or powdered milk (5% weight/vol) and exposed to membranes for approximately 1 hour. Mem-
branes were washed several times with PBS-TWEEN and imaged using the Typhoon Trio. In 
some cases, membranes were placed back into PBS-TWEEN containing milk (5% weight/vol) 
and exposed to Alexa Fluor 647-labeled anti-penta-His antibodies added to solution at a 
1:10,000 dilution for 1 hour, washed, and imaged. These experiments enabled secondary de-
tection of digoxigenin using the hexahistidine tag of the scFvs and served to probe the binding 
function of scFvs regardless of whether the antibody fragments in question were labeled with 
fluorescent dye. 
 
Kinetic characterization of soluble scFvs. A Biacore T100 instrument was used to deter-
mine the binding kinetics of scFvs using surface plasmon resonance. All assays were per-
formed on CM5 chips to which BSA and BSA-Dig were immobilized using standard amine 
coupling procedures for the T100 processing unit. Flow cells to which BSA was immobilized 
served as a means to double reference all data obtained on flow cells containing immobilized 
BSA-Dig. Two separate CM5 chips containing immobilized BSA and BSA-Dig were prepared 
and used to assay the binding kinetics of scFvs. One chip contained 92.9 response units of 
BSA immobilized to one flow cell and 12.7 response units of BSA-Dig immobilized to a second 
flow cell. The other chip contained one flow cell to which 39.7 response units of BSA was 
bound and three flow cells to which BSA-Dig was bound at response unit levels of 10.6, 5.4, 
and 45.9. Standard multicycle kinetics assays were performed at 25 °C on all scFvs of interest, 
including dye-labeled samples, using HBS EP+ (HBS +EDTA with 0.005 % surfactant P20) as 
a running buffer at a 90 µL/min flow rate. Surface regeneration was achieved by exposing the 
chip to glycine-HCl (10 mM glycine-HCl, pH 2.0) for 60 seconds (90 µL/min flow rate). scFv 
samples were injected onto the chip in concentrations ranging from 0.3125 to 40 nM in twofold 
increments (i.e., 0.3125, 0.625, 1.25, 2.5, 5, 10, 20, and 40 nM concentrations). Blank samples 
(no scFv) were also run, and each sample/blank was run twice during the course of an assay. 
Injection and dissociation times depended on the amino acids present in the scFv sample in 
question. scFvs containing Hpg were injected for a period of 180 seconds, while scFvs con-
taining all other amino acids were injected for 120 seconds. The dissociation of scFvs contain-
ing Aha from the chip surface was monitored for 650 seconds, while all other scFv dissocia-
tions were monitored for 450 seconds. All scFv samples (including those samples treated with 
6) were diluted to the final concentrations need for kinetic assays using HBS EP+, without di-
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alysis or other buffer exchange into the Biacore running buffer. Before assaying experimental 
samples, and in between different scFv samples, the chip was reconditioned using at least five 
startup cycles. 
 Kinetic constants for all scFvs were determined using Biacore T100 Evaluation soft-
ware. All binding curves were subjected to software-provided double referencing procedures 
before performing data fits using the standard 1:1 binding kinetic transport model provided with 
the software.[14] Data fits usually included all data up to and including 20 nM injections, exclud-
ing samples in which air bubbles or other deviations marred the sensorgrams. Most fitting 
could be performed without invoking significant mass transport limitations (mass transport 
constant kt ≥ 1010). However, all data taken on Hpg-containing fragments showed evidence of 
substantial mass transport limitation (kt ~106–108), meaning that the values for kon and koff re-
ported here for these scFvs may be slightly different from values determined in the absence of 
significant mass transport limitations.[15] All data reported here are the averages of independ-
ent experiments performed on the two chips prepared as described above, with a total of four 
determinations of kinetic parameters through data fitting on each chip surface containing im-
mobilized BSA-Dig. 
 
High-throughput sequencing. Frozen aliquots of Library 1 sorted three times after expres-
sion in media containing Hpg, Library 2 Hpg4x, Library 2 Aha4x, and Library 2 Nrl4x were 
thawed, diluted 1:200 into 2×YT KA (200 mL), and grown at 37 °C until the OD600 of each cul-
ture exceeded 1.0. The cultures were pelleted (15 minutes at 5000 × g, 4 °C), decanted, and 
frozen at −20 °C for at least 12 hours. Plasmid DNA from each sorted population was isolated 
using a Maxiprep kit. All DNA was digested using restriction enzymes BglII and PstI, and frag-
ments containing the Lpp-OmpA-scFv fusion gene (excluding Lpp and His tag portions of the 
gene) were separated from other DNA fragments via gel electrophoresis. DNA of each library 
population (approximately 1–3 µg) was submitted to the Millard and Muriel Jacobs Genetics 
and Genomics Laboratory at the California Institute of Technology for fragmentation and high-
throughput sequencing using the Illumina Genome Analyzer IIx platform (Illumina, San Diego, 
CA). DNA samples were subjected to fragmentation and cluster generation according to the 
manufacturer’s recommendations, and 38-base sequencing runs were performed on each 
sample (one lane/sample). Each run yielded over 3 × 107 sequencing reads on an estimated 
3.5–4.2 × 105 clusters. All data were aligned to the DNA sequence of pQE-80L-Antidig-HisGS-
Base, and the total number of calls of A, C, G, T, and N, at every position of each population 
was tallied using a script developed at the genomics laboratory. Every position within the con-
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struct was read at least 8,500 times in all populations. Substantial variation in the total num-
bers of reads at each position was observed (ranging from approximately 8,500 to more than 1 
million), most likely due to nonuniform fragmentation of the restriction fragment. However, 
even the minimum coverage of 8,500 yields good sampling of the populations to be character-
ized, which are the result of repeated isolations of no more than 20,000–30,000 sequence var-
iants via flow cytometry. All sequencing data were searched for positions at which 5% or more 
of the total reads indicated mutations from the nucleotide present in the base construct in a 
given population using scripts developed in Matlab (only single nucleotide mutations were 
considered in this analysis). Data are presented here on all positions at which at least one 
population displayed 5% deviation from pQE-80L-Antidig-HisGS-Base with the additional crite-
rion that the base call quality (Q, as defined by the Illumina analysis software) of at least one 
nucleotide (A, C, G, or T) at the position of interest exceeded 30. 
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Table S1. Amino acid mutations in clones isolated from Library 1 after sorting the library three 
times for clones tolerant of Hpg in place of Met. 
 
 
 
 
 
 
 
 
  
Clone M(H20) S(H24) M(H80) L(H82C) I(L2) A(L12) 
1 - P L - V - 
3 - - L - - - 
6 I - L - - T 
7 - - L - - - 
10 - - L - - - 
2 I - L M - - 
4 I - L M - - 
5 I - L M - - 
8 I - L M - - 
9 I - L M - - 
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Table S2. Summary of conditions used in flow cytometric sorting of Library 2. 
  
 Expression in Medium Containing 
Population Hpg (2.5 mM) Aha (0.28 mM) Nrl (0.30 mM) 
Naïve Library 2 
High Fluorescence High Fluorescence High Fluorescence 
   
1x sort 
High Fluorescence High Fluorescence High Fluorescence 
Lower Antigen Conc. Lower Antigen Conc. Lower Antigen Conc. 
2x sort 
Fluorescence, Viability Fluorescence, Viability Fluorescence, Viability 
15 minute competition 40 minute competition 8 minute competition 
3x sort 
Fluorescence, Viability Fluorescence, Viability Fluorescence, Viability 
40 minute competition 100 minute competition 15 minute competition 
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Table S3. Amino acid mutations in clones isolated from Library 2. 
†Truncated fragment. 
‡Missing amino acids 400−404.¶ 
¶Amino acids located after the end of the fragment are numbered according to their position within the open reading frame of the Lpp-OmpA-scFv fusion protein, starting at number one (initiator 
methionine; leader sequence included in numbering). 
  
Colony Notes E (H1) 
E 
(H10) 
L 
(H11) 
M 
(H20) 
S 
(H24) 
Y 
(H27) 
F 
(H29) 
T 
(H30) 
M 
(H34) 
H 
(H41) 
D 
(H46) 
Y 
(H53) 
Q 
(H61) 
M 
(H80) 
L 
(H82C) 
Y 
(H102) 
A 
(H107) 
S 
(H113) 
G 
(Linker1) 
G 
(Linker7) 
G 
(Linker9) 
Hpg4x1  - - - I Y - - - - - - - - L M - - - - - - 
Hpg4x3  - - - I F N - - - - - - - L M - - - - - - 
Hpg4x4  - - - I - N S - - - - - - L M - - - - - - 
Hpg4x5 † - - - I - - S - - - - - - L M - - - S - - 
Hpg4x6  - - - I - - - - - - - - - L M - - - - - - 
Hpg4x7  - - - I - - - - - - - - - L M - - - - - - 
Hpg4x8  - - - I Y - S - - - - - - L M N - - - - - 
Hpg4x9  - D - I - - - - - - - - - L M - - - - - - 
Hpg4x10  - - - L - - - - - - - - - L M - T - - - - 
Hpg4x11  - - - I F N - - - - - - - L M - - - - - - 
Hpg4x12 ‡ - - - I - - - - - - - - R L M - - - - - - 
Hpg3x1  - - M I Y - - - - N - - - L M - - - - - R 
Hpg3x2  - - - I - - - - - - E - - L M - - - - - - 
Hpg3x3  - - S I F - - S - - - - - L M - - - - - - 
Hpg3x4  - - - I - - S - - - - - - L M - - - - - - 
Hpg3x5  - - - I - - - - - - - - - L M - - - - - - 
Hpg3x6  - - - I F - - - - - - - - L M - - - - - - 
Aha3x1  - - - I - - - - - - - - - L M - - - - - - 
Aha3x2  - - - I - - S - - - - - - L M - - - - - - 
Aha3x3  - - - I - - - - - - - - - L M - - - - - - 
Aha3x4  - - - I - - S - - - - - - L M - - - - - - 
Aha3x5  - - - L - - S - - - - - - L - - - - - - - 
Aha3x6  - - - I - - - - - - - - - L M - - - - - - 
Aha4x1  - - - I Y - - - - - - - - L M - - - - - - 
Aha4x2 † - - - I Y - - - - - - - - L M - - - - - - 
Aha4x4  - - - I Y - - - I - - - - L M - - - - - - 
Aha4x5  - A - I - - S - - - - - - L - - - - - - V 
Aha4x6  - - - I - - - - - - - - - L M - - - - - - 
Nrl4x1  - - - I F N - - - - - - - L M - - - - - - 
Nrl4x2  - - - - Y - - - - - - - - L - - - - - - - 
Nrl4x3  G - - I F - S - - - - N - L M - - - - - - 
Nrl4x4  - - - I - - S - - - E - - L M - - - - - - 
Nrl4x5  - - - - - - S - - - - - - L - - - - - - - 
Nrl4x6  - - - - Y - S - - - - - - L - - - - - - - 
Nrl4x7  - - - I Y - - - - - - - - L - - - - - - - 
Nrl4x8  - - - I F N - - - - - - - L M - - - - - - 
Nrl4x9  - - - I - - S - V - - - - L M - - - - R - 
Nrl4x10  - - - I F N - - - - - - - L M - - - - - - 
Nrl4x11  - - - L Y - S - - - - - - L - - - F - - - 
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Table S3, continued. Amino acid mutations in clones isolated from Library 2. 
†Truncated fragment. 
‡Missing amino acids 400−404.¶ 
¶Amino acids located after the end of the fragment are numbered according to their position within the open reading frame of 
the Lpp-OmpA-scFv fusion protein, starting at number one (initiator methionine; leader sequence included in numbering). 
  
Colony Notes I (L2) 
A 
(L12) 
S 
(L22) 
S 
(L25) 
Q 
(L27) 
P 
(L40) 
N 
(L53) 
S 
(L64) 
E 
(L68) 
F 
(L71) 
T 
(L74) 
D 
(L76) 
V 
(L78) 
I 
(L85) K394
¶ R395¶ E404¶ 
Hpg4x1  - - - - - - - - - - - - - - - - - 
Hpg4x3  - - - - - - - - - - - - M - - - - 
Hpg4x4  - - - - - - - - - - - - - - - - - 
Hpg4x5 † - - - - - - - - - - - - - - Stop - - 
Hpg4x6  - - - - - - - - - - - - - - - - - 
Hpg4x7  - - F - - - - - - - - - - - - - - 
Hpg4x8  - - - - - - - - - - - - - - - - - 
Hpg4x9  - - - - - - - - - - - - - - - - - 
Hpg4x10  - - - - - - Y - - - - - - - - - - 
Hpg4x11  - - - - - - - - - - - - M - - - - 
Hpg4x12 ‡ - - - - - - - - - - - N - - - H - 
Hpg3x1  - - - - - - - - - - S N - - - - - 
Hpg3x2  - - - - - - - - - - - - - - - - - 
Hpg3x3  - - - - - - - - - - - - - - - - - 
Hpg3x4  - - - - - - - - - - - - - - - - - 
Hpg3x5  - - - - - - - - - - - - - - - - - 
Hpg3x6  - - - - - - - - - - - - - - - - - 
Aha3x1  - - - - - - - - - - - - - - - - - 
Aha3x2  - - - - - - - - D - - - - - - - - 
Aha3x3  - - - - - - - - - - - - - - - - - 
Aha3x4  - - - - - - - - - - - - - - - - - 
Aha3x5  - T - - - - - - - - - - - - - - - 
Aha3x6  - - - - - - - - - Y - - - - - - - 
Aha4x1  - - - - - - - - - - - - - - - - - 
Aha4x2 † - T - - K - - - - - - - - - - - Stop 
Aha4x4  - - - T - - - - - - - - - - - - - 
Aha4x5  - - - - - - - - - - - - - - - - - 
Aha4x6  - - - - - - - - - - - - - - - - - 
Nrl4x1  - - - - - - - - - - - - M - - - - 
Nrl4x2  - - - - - S - - - - - - - K - - - 
Nrl4x3  - - - - - - - - - - - - - - - - - 
Nrl4x4  - - - - - - - - - - - - - - - - - 
Nrl4x5  V - - - - - - T - - - - - - - - - 
Nrl4x6  - - - - - - - - - - - - - - - - - 
Nrl4x7  V - - - - - - - - - - - - - - - - 
Nrl4x8  - - - - - - - - - - - - M - - - - 
Nrl4x9  - - - - - - - - - - - - - - - - - 
Nrl4x10  - - - - - - - - - - - - M - - - - 
Nrl4x11  - - - - - - - - - - - - - - - - - 
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Table S4. Off-rate estimates performed using cell surface-displayed scFvs.* 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Cells displaying scFvs were subjected to off rate 
characterizations using an adaptation of the meth-
od of Daugherty et al.[11] (see Materials and Meth-
ods). Cells displaying the Nrl forms of scFvs were 
subjected to a less stringent wash procedure prior 
to estimating off rates. Errors reported are the 
95% confidence intervals in the fits as determined 
by the program Igor (Wavemetrics, Lake Oswego, 
OR). 
†A large portion of 5 appeared to have dissociated 
from cells prior to kinetic competition. 
‡Truncated antibody fragment.  
Hpg4x Clones 
Sample AA Context koff (10
-3 s−1) Remarks 
Mut2 Hpg 1.097 ± 0.081 † 
Base Met 0.672 ± 0.047  
Mut2 Met 0.528 ± 0.029  
Hpg4x1 Hpg 0.795 ± 0.059  
Hpg4x2 Hpg 1.153 ± 0.175 † 
Hpg4x3 Hpg 0.695 ± 0.021  
Hpg4x4 Hpg 0.912 ± 0.030  
Hpg4x5 Hpg 0.626 ± 0.016 ‡ 
Hpg4x6 Hpg 0.966 ± 0.070  
Hpg4x7 Hpg 1.368 ± 0.059  
Hpg4x8 Hpg 0.883 ± 0.040  
Hpg4x9 Hpg 0.914 ± 0.051  
Hpg4x10 Hpg 1.274 ± 0.090  
Hpg4x11 Hpg 0.871 ± 0.039  
Hpg4x12 Hpg 1.241 ± 0.087  
Hpg3x Clones 
Sample AA Context koff (10
-3 s–1) Remarks 
80L HisGS Met 0.490 ± 0.046  
Hpg3x1 Hpg 0.563 ± 0.012  
Hpg3x2 Hpg 1.372 ± 0.061  
Hpg3x3 Hpg 0.668 ± 0.033  
Hpg3x4 Hpg 0.906 ± 0.055  
Hpg3x5 Hpg 0.912 ± 0.026 † 
Hpg3x6 Hpg 1.021 ± 0.030  
Aha3x and Aha4x Clones 
Sample AA Context koff (10
–3 s–1) Remarks 
Base Met 0.661 ± 0.071  
Mut2 Met 0.506 ± 0.026  
Mut2 Aha 0.200 ± 0.007  
Aha3x1 Aha 0.054 ± 0.017  
Aha3x2 Aha 0.092 ± 0.019  
Aha3x3 Aha 0.161 ± 0.089  
Aha3x4 Aha 0.131 ± 0.016  
Aha3x5 Aha 0.193 ± 0.024  
Aha3x6 Aha 0.143 ± 0.013  
Aha4x1 Aha 0.061 ± 0.008  
Aha4x2 Aha 0.086 ± 0.014 ‡ 
Aha4x4 Aha 0.122 ± 0.021  
Aha4x5 Aha 0.076 ± 0.018  
Aha4x6 Aha 0.154 ± 0.024  
Nrl4x Clones 
Sample AA Context koff (10
–3 s–1) Remarks 
Base Met 0.736 ± 0.061  
Mut2 Met 0.533 ± 0.030  
Base Nrl 1.364 ± 0.047  
Mut2 Nrl 1.224 ± 0.023  
Nrl4x1 Nrl 0.509 ± 0.019  
Nrl4x2 Nrl 0.518 ± 0.026  
Nrl4x3 Nrl 0.366 ± 0.056  
Nrl4x4 Nrl 0.745 ± 0.025  
Nrl4x5 Nrl 0.787 ± 0.045  
Nrl4x6 Nrl 1.025 ± 0.243  
Nrl4x7 Nrl 0.435 ± 0.030  
Nrl4x8 Nrl 0.514 ± 0.024  
Nrl4x9 Nrl 0.494 ± 0.047  
Nrl4x10 Nrl 0.548 ± 0.022  
Nrl4x11 Nrl 0.262 ± 0.020  
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Table S5. Frequently mutated positions (>5%) of scFvs identified in high-throughput sequenc-
ing of sorted populations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Nucleotide numbering scheme based on position 1 in pQE-80L as defined by the 
manufacturer (Qiagen) and adapted to the Lpp-OmpA-scFv variant plasmids. 
†Numbering scheme same as in Table S3. 
 
  
Nucleotide 
Position* Base 
Frequent 
Mutation 
Amino Acid 
Mutation† 
Mutational Frequency 
Library 1  
Hpg Sort 3 Lib2 Hpg4x Lib2 Aha4x Lib2 Nrl4x 
678 c t  0.00 0.04 0.13 0.00 
693 g a,c M(H20)I 0.73 0.86 0.94 0.57 
703 t c S(H24)P 0.06 0.03 0.01 0.02 
704 c a S(H24)Y 0.03 0.18 0.32 0.34 
  t S(H24)F 0.01 0.11 0.24 0.21 
712 t a S(H27)N 0.00 0.03 0.01 0.12 
  c S(H27)H 0.00 0.01 0.00 0.01 
719 t c F(H29)S 0.02 0.32 0.29 0.56 
721 a c T(H30)P 0.01 0.05 0.07 0.02 
733 a g M(H34)V 0.00 0.02 0.01 0.18 
735 g a M(H34)I 0.00 0.02 0.05 0.04 
771 c a D(H46)E 0.01 0.13 0.03 0.05 
803 t c V(H56)A 0.00 0.01 0.00 0.06 
847 g t V(H71)F 0.00 0.01 0.01 0.03 
  a V(H71)I 0.00 0.00 0.00 0.02 
861 c a,t,g  0.00 0.05 0.00 0.05 
874 a t,c M(H80)L 0.90 0.99 0.99 0.86 
889 t a L(H82C)M 0.62 0.71 0.78 0.50 
955 t c Y(H102)H 0.00 0.00 0.00 0.03 
  a Y(H102)N 0.00 0.05 0.01 0.03 
970 g a A(H107)T 0.01 0.08 0.11 0.00 
1002 c t  0.00 0.01 0.08 0.00 
1018 t g S(Linker10)A 0.01 0.00 0.01 0.01 
  c S(Linker10)P 0.00 0.00 0.08 0.00 
1039 a g I(L2)V 0.06 0.09 0.05 0.13 
1069 g a A(L12)T 0.08 0.05 0.07 0.09 
1078 c a L(L15)I 0.01 0.05 0.15 0.00 
1086 a g  0.00 0.00 0.05 0.01 
1095 g a  0.01 0.00 0.06 0.06 
1099 t c S(L22)P 0.03 0.00 0.24 0.24 
1108 t a S(L25)T 0.00 0.01 0.06 0.00 
1110 c a  0.00 0.01 0.00 0.07 
1114 c a Q(L27)K 0.00 0.04 0.15 0.00 
1209 c t  0.06 0.07 0.04 0.02 
1236 c t  0.00 0.03 0.00 0.14 
1257 a g,t  0.00 0.02 0.13 0.00 
1282 g a V(L78)M 0.00 0.03 0.00 0.16 
1296 t c  0.00 0.00 0.08 0.00 
1350 g t  0.00 0.00 0.06 0.01 
1399 g t E404Stop 0.00 0.05 0.17 0.00 
  a E404K 0.00 0.01 0.00 0.00 
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Table S6. Characterization of soluble scFvs: expression yields, binding kinetics, and amino 
acid replacement estimates. 
*Expression yields were calculated based on bicinchoninic acid (BCA) assays of concentrated protein samples after size ex-
clusion chromatography. 
†Binding kinetics were determined using a Biacore T100 instrument. Digoxigenin (antigen) was immobilized on the 
surface of CM5 chips using a two-step immobilization process. First, antigen was conjugated to bovine serum al-
bumin (BSA). This conjugate was then attached to the chip using standard amine coupling procedures. Multicycle 
kinetic assays using a range of scFv concentrations from 0.3125 to 20 nM were used to obtain kinetic parameters. 
The parameters reported here are the result of two independent assays performed on four chip surfaces having a 
range of ligand densities, displayed as averages plus or minus standard deviations. Kinetics were well-described 
by a standard 1:1 binding transport model. In the case of Hpg-containing fragments, a significant mass transport 
constant was invoked in the best fits of the data. All other data were found to be free of substantial mass transport 
limitations. 
‡Amino acid replacement levels were estimated on the basis of matrix-assisted laser desorption ionization (MALDI) 
mass spectrometry of trypsinized scFv samples as described in Materials and Methods. Data are reported as the 
mean plus or minus the standard deviation of two or more independent trypsinizations and MALDI mass spectrum 
acquisitions. 
 
  
AA Context Met Hpg 
Clone Exp. Yield (mg/L)* kon (10
6 M–1s–1)† koff (10
–3 s–1) Exp. Yield (mg L–1) % Met replacement‡ kon (10
6 M–1s–1) koff (10
–3 s–1) 
Base 0.63 1.35 ± 0.08 1.85 ± 0.15     
Mut2 1.43 1.50 ± 0.16 1.72 ± 0.17 0.73 86 ± 4 2.23 ± 0.44 8.09 ± 0.53 
Hpg3x1 1.17 1.29 ± 0.40 1.92 ± 0.29 1.47 90 ± 2 2.31 ± 0.34 6.54 ± 1.41 
Hpg3x3 0.77 1.42 ± 0.12 0.93 ± 0.07 0.62 89 ± 0.4 1.80 ± 0.21 4.63 ± 0.34 
Hpg4x3 2.44 1.45 ± 0.10 1.08 ± 0.09 0.26 87 ± 3 1.37 ± 0.12 6.61 ± 0.73 
Hpg4x8 1.61 1.59 ± 0.05 1.03 ± 0.09 0.47 89 ± 4 1.31 ± 0.08 5.59 ± 1.42 
        
AA Context Met Aha 
Clone Exp. Yield (mg/L) kon (10
6 M–1s–1) koff (10
–3 s–1) Exp. Yield (mg L–1) % Met replacement kon (10
6 M–1s–1) koff (10
–3 s–1) 
Base 0.63 1.35 ± 0.08 1.85 ± 0.15     
Mut2 1.43 1.50 ± 0.16 1.72 ± 0.17 0.98 84 ± 1 1.20 ± 0.11 0.96 ± 0.16 
Aha3x2 1.59 1.72 ± 0.08 1.50 ± 0.14 1.34 80 ± 4 1.58 ± 0.18 0.81 ± 0.12 
Aha4x4 2.31 1.41 ± 0.09 1.00 ± 0.19 1.21 Not determined 1.44 ± 0.28 0.70 ± 0.15 
Aha4x5 1.44 1.55 ± 0.15 1.31 ± 0.29 0.86 83 ± 4 1.93 ± 0.47 0.68 ± 0.11 
        
AA Context Met Nrl 
Clone Exp. Yield (mg/L) kon (10
6 M–1s–1) koff (10
–3 s–1) Exp. Yield (mg L–1) % Met replacement kon (10
6 M–1s–1) koff (10
–3 s–1) 
Base 0.63 1.35 ± 0.08 1.85 ± 0.15 Not determined 86 0.54 ± 0.36 2.31 ± 0.39 
Mut2 1.43 1.50 ± 0.16 1.72 ± 0.17 1.12 88 ± 5 1.34 ± 0.07 2.07 ± 0.20 
Nrl4x3 4.98 1.73 ± 0.06 1.08 ± 0.04 2.22 87 ± 5 1.90 ± 0.14 1.16 ± 0.10 
Nrl4x4 4.07 1.39 ± 0.03 2.23 ± 0.19 1.53 93 ± 2 1.58 ± 0.16 2.51 ± 0.07 
Nrl4x11 0.91 1.26 ± 0.12 0.93 ± 0.09 0.64 89 ± 3 1.19 ± 0.02 1.08 ± 0.07 
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Table S7. Amino acid mutations in clones produced in soluble form. 
 
  
Colony E (H1) 
E 
(H10) 
L 
(H11) 
M 
(H20) 
S 
(H24) 
Y 
(H27) 
F 
(H29) 
T 
(H30) 
M 
(H34) 
H 
(H41) 
D 
(H46) 
Y 
(H53) 
M 
(H80) 
L 
(H82C) 
Y 
(H102) 
S 
(H113) 
G 
(Linker9) 
S 
(L25) 
E 
(L68) 
T 
(L74) 
D 
(L76) 
V 
(L78) 
Hpg3x1 - - M I Y - - - - N - - L M - - R - - S N - 
Hpg3x3 - - S I F - - S - - - - L M - - - - - - - - 
Hpg4x3 - - - I F N - - - - - - L M - - - - - - - M 
Hpg4x8 - - - I Y - S - - - - - L M N - - - - - - - 
Aha3x2 - - - I - - S - - - - - L M - - - - D - - - 
Aha4x4 - - - I Y - - - I - - - L M - - - T - - - - 
Aha4x5 - A - I - - S - - - - - L - - - V - - - - - 
Nrl4x3 G - - I F - S - - - - N L M - - - - - - - - 
Nrl4x4 - - - I - - S - - - E - L M - - - - - - - - 
Nrl4x11 - - - L Y - S - - - - - L - - F - - - - - - 
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Table S8. Dye labeling of Met- and Aha-containing proteins using 6. 
 
 
 
 
  
Protein Aha3x2 Aha4x4 Aha4x5 
AA Context Met Aha Met Aha Met Aha 
Dyes/Protein 0.00 ± 0.00 0.43 ± 0.15 0.00 ± 0.00 0.04 ± 0.05 0.00 ± 0.00 0.38 ± 0.20 
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Table S9. Kinetic characterization of scFvs before and after reaction with 6 (strain-promoted 
click chemistry)*. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Kinetic characterizations were performed as described in Table S6 and Mate-
rials and Methods. Clicked scFv samples were prepared for Biacore assays 
without separating unreacted dyes or quenching reagents from solution. 
 
  
AA Context Met 
 No Click Chemistry Click Chemistry 
Clone kon (10
6 M–1s–1) koff (10
–3 s–1) kon (10
6 M–1s–1) koff (10
–3 s–1) 
Aha3x2 1.72 ± 0.08 1.50 ± 0.14 1.03 ± 0.03 1.38 ± 0.14 
Aha4x4 1.41 ± 0.09 1.00 ± 0.19 0.75 ± 0.15 0.92 ± 0.25 
Aha4x5 1.55 ± 0.15 1.31 ± 0.29 1.16 ± 0.16 1.29 ± 0.23 
AA Context Aha 
 No Click Chemistry Click Chemistry 
Clone kon (10
6 M–1s–1) koff (10
–3 s–1) kon (10
6 M–1s–1) koff (10
–3 s–1) 
Aha3x2 1.58 ± 0.18 0.81 ± 0.12 0.79 ± 0.07 0.70 ± 0.10 
Aha4x4 1.44 ± 0.28 0.70 ± 0.15 0.93 ± 0.15 0.63 ± 0.17 
Aha4x5 1.93 ± 0.47 0.68 ± 0.11 1.09 ± 0.08 0.71 ± 0.14 
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Table S10. Oligonucleotides used in study. 
 
 
  
Name Sequence 
EcoRiElimFwd 5’-GTTTTTTTGGGCTAGCGTTTTCGAGCTCGGTACC-3’ 
EcoRIElimRev 5'-GGTACCGAGCTCGAAAACGCTAGCCCAAAAAAAC-3' 
Lpp-OmpA-antidigFwd 5’-GAATTCGAGCTCGGTACCCGGGCTAGAG-3’ 
Lpp-OmpA-antidigRev1 5’-GTGATGAGAACCACGGTCCTCGGGGTCTTCCGGG-3’ 
Lpp-OmpA-antidigRev1 5’-TGCTCTAAGCTTACTAGTGATGGTGATGGTGATGAGAACCACGGTCCTC-3’ 
HindIIIElimFwd 5’-GAAACCAGGACAGCCACCCAAACTACTCATCTATAAGGTATCC-3’ 
HindIIIElimRev 5’-GGATACCTTATAGATGAGTAGTTTGGGTG GCTGTCCTGGTTTC-3’ 
LppHisRescue 5’- CGTGGTTCTCATCACCATCACCATCACGGCTCGTAGTAAGCTTAGAGCA-3’ 
80LLibFwd 5’-CAATTGTGAGCGGATAACAATTTCAC-3’ 
80LLibRev 5’-GCTCCTGAAAATCTCGCCAAGCTAGC-3’ 
PstIAddFwd 5’-CTAAAATCGATCAGGGAATTAACCTGCAGGTTGGCTTTGAAATGGGTTAC-3’ 
PstIAddRev 5’-GTAACCCATTTCAAAGCCAACCTGCAGGTTAATTCCCTGATCGATTTTAG-3’ 
PstIElimFwd 5’-GATGATGCTGCAATATATTATTGTAGCCAAACTACGCATGTTCC-3’ 
PstIElimRev 5’-GGAACATGCGTAGTTTGGCTACAATAATATATTGCAGCATCATC-3’ 
BglIIAddFwd 5’-GCCAGCCAGAACTCGCCCCGGAAGATCTCGAGGACCGTGGTTCTCATC-3’ 
BglIIAddRev 5’-GATGAGAACCACGGTCCTCGAGATCTTCCGGGGCGAGTTCTGGCTGGC-3’ 
AntidigpAK400Fwd 5'-ATATAAGGCCCAGCCGGCCATGGCGGGAATTCGTGAAGTTCAACTGCAAC-3' 
AntidigpAK400Rev 5'-CTCGCCCCGGAAGATCTCGAGGACGCGGCCTCGGGGGCCAATATA-3' 
AntidigpAK400FwdNrl4x3 5'-ATATAAGGCCCAGCCGGCCATGGCGGGAATTCGAGGAGTTCAACTGCAAC-3' 
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Figure S1. Fluorescence-activated cell sorting of Library 1 for clones that function when Met is 
replaced by Hpg. Expression of cells harboring the naïve library and sorted populations was 
performed in minimal media containing concentrations of Met and Hpg as indicated. After 
treatment of induced cells with 5, the fluorescence of each sample was measured on the flow 
cytometer. Boxed populations were sorted, and events falling into the top ~0.1% of fluores-
cence measurements in the BODIPY FL channel were retained for the next round of sorting. 
Note that the naïve library was sorted after induction in medium containing 20 µM Met and 2.5 
mM Hpg. The addition of Met to the media results in a population exhibiting an intermediate 
level of fluorescence compared to samples induced in Met or Hpg only, implying a partial re-
placement of Met with Hpg. AA, amino acid. µ, mean fluorescence. 
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Figure S2. Fluorescence-activated cell sorting of Library 2 for clones that function when Met is 
replaced by ncAAs. Expression of the naïve library and sorted populations was performed in 
minimal media containing concentrations of ncAAs as indicated. The fluorescence of each 
population was determined by flow cytometry. Starting with “Sort 2” in each amino acid con-
text, cells were washed twice prior to flow cytometry. Each sample was subjected to labeling 
and kinetic competitions as outlined in Table S2; the top ~0.1%–1.0% of fluorescent events 
were retained. AA, amino acid. µ, mean fluorescence. 
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Figure S3. Strain-promoted click chemistry on scFvs using fluorescently labeled compound 6. 
Solutions of the Met and Aha forms of scFv variants at 1.75 µM concentrations were subjected 
to reactions with 10 µM 6 for a period of 1 hour. After quenching the reactions with excess 3-
azidopropanol, protein samples were subjected to sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE). A Typhoon Trio imaging system was used to confirm scFv label-
ing. 
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Figure S4. MALDI mass spectrometry on trypsinized fragments of the Aha forms of Aha4x5, 
Aha3x2, and Aha4x4 before and after reaction with 6. A) MALDI mass spectrometry on tryp-
sinized samples of the Aha form of Aha4x5 before and after reaction with 6. The peak identi-
fied as “Unmodified” includes the Aha residue located at position H34 and has sequence 
SSGYISTDFYAhaNWVR ([M+H]+ calculated: 1820.83 Da, [M+H]+ observed (unclicked): 
1820.65 Da). The peak labeled “Modified” is the same peptide after reaction with 6 ([M+H]+ 
calculated: ~2654.96 Da, [M+H]+ observed (clicked): 2656.22 Da), and is present in the mass 
spectrum only after click chemistry (“click” spectrum offset by 10 Da and 1000 counts for clari-
ty). B) MALDI mass spectrometry on trypsinized samples of the Aha form of Aha3x2 before 
and after reaction with 6. The peak identified as “Unmodified” includes the Aha residue located 
at position H34 and has sequence SSGYISTDFYAhaNWVR ([M+H]+ calculated: 1820.83 Da, 
[M+H]+ observed (unclicked): 1820.26 Da). The peak labeled “Modified” is the same peptide 
after reaction with 6 ([M+H]+ calculated: ~2654.96 Da, [M+H]+ observed (clicked): 2656.43 
Da), and is present in the mass spectrum only after click chemistry (“click” spectrum offset by 
10 Da and 1000 counts for clarity). C) MALDI mass spectrometry on trypsinized samples of 
the Aha form of Aha4x4 before and after reaction with 6. The peak identified as “Unmodified” 
includes position H34 (Met (Aha) mutated to Ile) and has sequence YSGYIFTDFYINWVR 
([M+H]+ calculated: 1943.94 Da, [M+H]+ observed: 1943.86 Da). No new peaks are visible in 
the mass spectrum of the “clicked” sample (“click” spectrum offset by 10 Da and 1000 counts 
for clarity). 
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Figure S5. Positions of Met residues and residues mutated to Met in scFv form of 26-10 anti-
body. Each site in the protein that is occupied by Met in at least one soluble variant is shown in 
space filling representation, with surface accessibilities calculated from GetArea listed beneath 
the residue of interest. The accessibility numbers reported here are the average of three calcu-
lations performed using PDB files 1IGI (1 Fab molecule/unit cell) and 1IGJ (2 Fab mole-
cules/unit cell, complexed to ligand).[16] The backbone of the Fv portion of the Fab is outlined 
with a ribbon diagram (gray), with amino acids of interest shown in space filling representation 
and antigen shown as sticks in white. H, heavy chain. L, light chain. Space filling residues col-
ored by elements: carbon, gray; oxygen, red; nitrogen, blue; sulfur, yellow. 
  
 
 
34 
 
Figure S6. Flow cytometry of the Met and Aha forms of cell surface-displayed Aha4x5 to probe 
binding function and chemical modification with strained alkynes. The two-dimensional dot 
plots show simultaneous measurements of the amounts of 5 (a measurement of binding func-
tion) and streptavidin-phycoerythrin (SA-PE; a measure of reactivity toward cyclooctyne 7) 
bound to the cell surface. Mean fluorescence values for 5 (denoted “BD µ”) and SA-PE (de-
noted “PE µ”) are indicated on each plot. A) Cells displaying the Met form of Aha4x5 without 
treatment with fluorescent probes. B) Probes of binding function of cells using 5, with amino 
acid context and treatment with 7 (i.e., strain-promoted click chemistry) as noted in panels. 
Some reduction in the amount of 5 bound per cell is noted upon treatment of the Aha form of 
Aha4x5 with 7. This may be attributable to steric effects on the cell surface after treatment with 
7 or the denaturation of some scFvs during the click reaction. C) Probes of the extent of modi-
fication of cells using SA-PE, with amino acid context and treatment with 7 as noted in panels. 
D) Use of 5 and SA-PE to probe binding and modification simultaneously, with amino acid con-
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text and treatment with 7 as noted in panels. Simultaneous examination of these two proper-
ties on the cell surface gives results consistent with those of experiments in which binding and 
modification were assessed separately. E) Adding unlabeled digoxin to the Aha form of cells 
expressing Aha4x5 treated with 7 prior to treatment with 5 and SA-PE results in cells unable to 
bind to fluorescent antigen while retaining modification. F) Use of 5 and SA-PE to probe the 
function and modification of uninduced cells harboring plasmids encoding the Aha4x5 cell sur-
face display construct. Amino acid context and treatment with 7 as noted in panels. The mean 
PE fluorescence of cells grown in medium supplemented with Aha and treated with 7 is less 
than one quarter of the mean PE fluorescence of cells displaying the Aha form of Aha4x5 and 
treated with 7, suggesting that scFv labeling is responsible for approximately 75 percent of to-
tal cell labeling. G) Use of 5 and SA-PE to probe for antigen binding and biotin modification of 
cells lacking the plasmid for the cell surface-displayed Aha4x5 construct. Amino acid context 
and treatment with 7 as noted in panels. The mean PE fluorescence of cells lacking the dis-
play plasmid, grown in Aha, and treated with 7 is similar to the mean PE fluorescence of unin-
duced cells harboring the display plasmid, grown in Aha, and treated with 7, suggesting that 
the observed increase in fluorescence observed in panels (F) and (G) comes from labeling of 
newly synthesized membrane proteins during the course of induction, not leaky expression 
from the display construct. 
